Dr. Yao discusses ASH 2024 study on non-CLL-type MBL
Recorded at the 66th American Society of Hematology Annual Meeting and Exposition, Yuan Yao, MD, MS, discusses the ASH abstract (No.397) titled, “Prevalence,
66th American Society of Hematology Annual Meeting & Exposition
Leukemia
Meetings / Conferences
66th American Society of Hematology Annual Meeting & Exposition
Meetings / Conferences
AI chatbot trained on ASH guidelines gives hematology advice
ASH-Gbot, an AI-driven chatbot trained on the American Society of Hematology (ASH) guidelines, is able to deliver disease-specific advice for hematological conditions with
Meetings / Conferences
Society Updates
The Twelfth Annual Meeting of the Society of Hematologic Oncology
Save the date: SOHO MENA all set for 12/19/24
After being postponed due to the war in the Middle East, SOHO MENA is very excited to announce that the hybrid meeting will
66th American Society of Hematology Annual Meeting & Exposition
MDS
Meetings / Conferences
Dr. Santini talks MDS ASH highlights from San Diego
In this video filmed at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, Valeria Santini, MD, an associate professor of
Lymphoma
Society Updates
The Twelfth Annual Meeting of the Society of Hematologic Oncology
Dr. Kriachok: attending SOHO 2024 was a ‘great honor’
Iryna Kriachok, MD, PhD, of the National Cancer Institute in Kyiv, Ukraine, explains in both Ukrainian and English why being invited to the
66th American Society of Hematology Annual Meeting & Exposition
Myeloma
Daratumumab monotherapy superior to active monitoring in high-risk smoldering myeloma
Daratumumab demonstrated a clinically meaningful and significant benefit compared with active monitoring, the current standard of care, for patients with high-risk smoldering multiple
66th American Society of Hematology Annual Meeting & Exposition
Lymphoma
Meetings / Conferences
News
Dr. Lu discusses CD7-targeted CAR-T cell therapy at ASH 2024
Peihua Lu, MD, of Beijing Lu Daopei Institute of Hematology in China, stopped by the SOHO booth to speak with SOHO Insider during
Multiple Myeloma
News
Introducing SOHO Insider
SOHO Insider EIC Sagar Lonial, MD, announces the new digital and print newsroom SOHO Insider from the Society of Hematologic Oncology (SOHO).
66th American Society of Hematology Annual Meeting & Exposition
Leukemia
Fixed-duration regimens outperform SOC in treatment-naïve CLL
Fixed-duration acalabrutinib plus venetoclax with or without obinutuzumab improved progression-free survival over fludarabine-cyclophosphamide-rituximab or bendamustine-rituximab in treatment-naïve chronic lymphocytic leukemia (TN CLL), according
66th American Society of Hematology Annual Meeting & Exposition
Leukemia
Asciminib benefit-risk profile bests other TKIs in CML
Results from the phase 3 ASC4FIRST study presented at the 2024 American Society of Hematology Annual Meeting & Exposition showed that asciminib had